Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions ...Middle East

News by : (PR Newswire) -
PARIS, Nov. 2, 2020 /PRNewswire/ -- Corlieve Therapeutics today announced the closing of its seed financing led by Kurma Partners and IDinvest Partners, together with Pureos Bioventures. Corlieve is focused on developing novel therapeutics for severe neurological disorders. Corlieve's...

Read More Details
Finally We wish PressBee provided you with enough information of ( Corlieve Therapeutics SAS Closes Seed Financing to Develop Therapies for Severe Neurological Conditions )

Also on site :

Most Viewed News
جديد الاخبار